Precipio Inc - SIC # 3826 - LABORATORY ANALYTICAL INSTRUMENTS

Ticker Exchange SIC # Website Latest Ticker
PRPO Nasdaq 3826 http://www.precipiodx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Precipio Inc

Precipio Ships First IV-Cell® Order to Major US Healthcare System - Mar 21st, 2023 2:30 pm
CORRECTION -- Precipio continues to sign up and onboard HemeScreen™ customers - Mar 7th, 2023 5:49 pm
Precipio continues to sign up and onboard HemeScreen™ customers - Mar 7th, 2023 5:00 pm
ThermoFisher Salesforce Votes Precipio’s HemeScreen® as “Best New Product” - Feb 14th, 2023 4:44 pm
Precipio Signs Another Major HemeScreen™ Customer - Jan 11th, 2023 3:00 pm
Precipio Signs Additional Major HemeScreen™ Customer - Dec 6th, 2022 3:00 pm
Precipio Presents Poster on HemeScreen® Study at Association of Molecular Pathology (AMP) 2022 Annual Conference - Nov 7th, 2022 3:30 pm
Precipio Announces Third Quarter Shareholder Update Call - Nov 2nd, 2022 9:00 pm
Precipio, Inc. (NASDAQ:PRPO) Is Expected To Breakeven In The Near Future - Oct 18th, 2022 1:07 pm
Precipio Signs Agreement with Another Major US Healthcare Distributor for HemeScreen™ - Sep 15th, 2022 3:00 pm
Sharon Robins Joins Precipio’s Products Division as Senior Director of Laboratory & Hospital Sales - Aug 24th, 2022 3:00 pm
Precipio Launches New 1-Step Technology for all HemeScreen Assays - Aug 16th, 2022 3:00 pm
Toni-Ann Mills Joins Precipio’s Products Division to Lead Channel Partner Training, Learning & Development - Aug 10th, 2022 2:00 pm
Precipio Announces Second Quarter Shareholder Update Call - Aug 8th, 2022 2:00 pm
Precipio to distribute HemeScreen® through Fisher Healthcare channel - Jul 20th, 2022 2:30 pm
Precipio requests that all Stockholders that have not yet voted, proceed to cast their vote - Jun 14th, 2022 6:00 pm
Keith Meadors Joins Precipio to Lead its Products Division - Jun 13th, 2022 3:00 pm
Precipio Receives CE-IVD Certification to Market Multiple HemeScreen® Panels in Europe - May 24th, 2022 2:30 pm
When Will Precipio, Inc. (NASDAQ:PRPO) Breakeven? - May 11th, 2022 12:15 pm
Precipio Signs First IV-Cell Customer Agreement - May 10th, 2022 2:30 pm